Pyrosequencing sets up new distributors in Asia Pacific region

22 July 2001

Sweden's Pyrosequencing AB has completed the worldwide distributionnetwork for its DNA sequencing and analysis systems to include the major markets in the Asia Pacific region.

As well as existing distributorships or direct marketing in the USA, Japan and Europe, Pyrosequencing has now signed up with Millennium Science for Australia, New Zealand, Singapore and Malaysia; Bio-Medical Science for Korea; Biowell Technology for Taiwan; and Gene Company in China and Hong Kong. These arrangements, the company said, will complement its existing distribution in Japan with Sumitomo.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight